PETMED EXPRESS INC (PETS)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 03-31. Amounts in USD.

2Y 5Y 10Y All
Quarterly Annual TTM

Revenue Annual

0 150M 300M 450M FY16: 234.7M FY17: 249.2M FY18: 273.8M FY19: 283.4M FY20: 284.1M FY21: 303.6M FY22: 272.3M FY23: 247.6M FY24: 274.1M FY25: 227M FY26: 179M FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25 FY26

Gross Profit Annual

0 35M 70M 105M FY10: 91.9M FY11: 84M FY12: 80.2M FY13: 77.1M FY14: 77.6M FY15: 76.3M FY16: 76.3M FY17: 79.3M FY18: 97.8M FY19: 95.3M FY20: 81.2M FY21: 84.3M FY22: 76.9M FY23: 76.5M FY24: 84.8M FY25: 69.1M FY26: 50.2M FY10 FY12 FY14 FY16 FY18 FY20 FY22 FY24 FY26

Operating Income Annual

-60M -40M -20M 0 20M 40M 60M FY10: 40.5M FY11: 33M FY12: 26M FY13: 27M FY14: 28.2M FY15: 27.6M FY16: 32.4M FY17: 37.5M FY18: 52.1M FY19: 46.2M FY20: 31M FY21: 30.5M FY22: 24.3M FY23: 6.1M FY24: -8.2M FY25: -1.5M FY26: -58.7M FY10 FY12 FY14 FY16 FY18 FY20 FY22 FY24 FY26

Net Income Annual

-60M -40M -20M 0 20M 40M 60M FY10: 26M FY11: 20.9M FY12: 16.7M FY13: 17.2M FY14: 18M FY15: 17.5M FY16: 20.6M FY17: 23.8M FY18: 37.3M FY19: 37.7M FY20: 25.9M FY21: 23.9M FY22: 18.7M FY23: 5.1M FY24: -7.5M FY25: -6.3M FY26: -57.3M FY10 FY12 FY14 FY16 FY18 FY20 FY22 FY24 FY26

Cost of Revenue Annual

0 80M 160M 240M FY16: 158.4M FY17: 169.9M FY18: 176M FY19: 188.1M FY20: 202.9M FY21: 219.3M FY22: 195.3M FY23: 171.1M FY24: 189.3M FY25: 157.8M FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Operating Cash Flow Annual

-40M -20M 0 20M 40M 60M FY10: 27.7M FY11: 30.1M FY12: 20.4M FY13: 13.3M FY14: 13.5M FY15: 32M FY16: 21.1M FY17: 47.2M FY18: 37.4M FY19: 45.1M FY20: 38.8M FY21: 40.1M FY22: 18.5M FY23: 27.8M FY24: 4.3M FY25: 4.7M FY26: -28.4M FY10 FY12 FY14 FY16 FY18 FY20 FY22 FY24 FY26

Free Cash Flow Annual

-40M -20M 0 20M 40M 60M FY10: 26.6M FY11: 29.4M FY12: 19.7M FY13: 12.7M FY14: 13.5M FY15: 31.1M FY16: 923K FY17: 36.6M FY18: 36.7M FY19: 44.5M FY20: 36.5M FY21: 37.6M FY22: 16.7M FY23: 22.5M FY24: -194K FY25: -395K FY26: -33M FY10 FY12 FY14 FY16 FY18 FY20 FY22 FY24 FY26

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 8M 16M 24M FY10: 22.7M FY11: 22.6M FY12: 20.7M FY13: 20M FY14: 20K FY15: 20.1M FY16: 20.3M FY17: 20.4M FY18: 20.4M FY19: 20.5M FY20: 20.1M FY21: 20.1M FY22: 20.4M FY23: 20.3M FY24: 20.4M FY25: 20.6M FY26: 20.9M FY10 FY12 FY14 FY16 FY18 FY20 FY22 FY24 FY26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-4.50 -3.00 -1.50 0.00 1.50 3.00 4.50 Q3 '12: 0.78 Q4 '12: 0.80 Q1 '13: 0.78 Q2 '13: 0.79 Q1 '14: 0.90 Q2 '14: 0.91 Q3 '14: 0.91 Q4 '14: 0.91 Q1 '15: 0.92 Q2 '15: 0.85 Q3 '15: 0.86 Q4 '15: 0.88 Q1 '16: 0.92 Q3 '17: 1.07 Q4 '17: 1.17 Q1 '18: 1.30 Q2 '18: 1.49 Q3 '18: 1.69 Q4 '18: 1.82 Q1 '19: 1.99 Q2 '19: 2.08 Q3 '19: 2.02 Q4 '19: 1.84 Q1 '20: 1.48 Q2 '20: 1.29 Q3 '20: 1.25 Q4 '20: 1.28 Q1 '21: 1.41 Q2 '21: 1.50 Q3 '21: 1.54 Q4 '21: 1.53 Q1 '22: 1.36 Q2 '22: 1.25 Q3 '22: 1.08 Q4 '22: 1.04 Q1 '23: 0.95 Q2 '23: 0.78 Q3 '23: 0.56 Q4 '23: 0.25 Q1 '24: 0.06 Q2 '24: -0.05 Q3 '24: -0.14 Q4 '24: -0.38 Q1 '25: -0.14 Q2 '25: -0.06 Q3 '25: 0.01 Q4 '25: -0.30 Q1 '26: -2.13 Q2 '26: -2.65 Q3 '26: -3.12 Q4 '26: -2.75 Q1 '27: -1.38 Q1 '13 Q2 '15 Q2 '18 Q1 '20 Q4 '21 Q3 '23 Q2 '25 Q1 '27

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.